COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news

The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on plant and animal patentability and new global initiatives in IP law enforcement.

Read more about COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news

Patent office extends all deadlines to 18th May 2020, WIPO launches COVID-19 IP Policy Tracker and more patent news

The Indian Patent Office has extended all deadlines for IP filings to 18th May 2020 due to the ongoing lockdown. WIPO has launched a COVID-19 IP Policy Tracker, and the USPTO now allows plant patent applications via electronic systems. This post highlights key patent and IP news updates from India and abroad.

Read more about Patent office extends all deadlines to 18th May 2020, WIPO launches COVID-19 IP Policy Tracker and more patent news

25000+ patent applications examined till date, general decrease in activity at IPO

This week’s Indian patent statistics reveal a general decrease in activity at the IPO, with reductions in publications and grants. Over 25000 patent applications have been examined to date, while design registrations show a moderate increase. Data is compiled and presented by BananaIP Counsels.

Read more about 25000+ patent applications examined till date, general decrease in activity at IPO

AI cannot be an inventor rules USPTO, IPO extends SIPP Scheme and other patent news

The USPTO has ruled that AI cannot be named as a patent inventor, aligning with recent decisions by UKIPO and EPO. The Indian Patent Office has extended the SIPP Scheme, while CSIR allows deferred payments for COVID-19 related IP. Key updates also include Gilead’s global access strategy for Remdesivir and new developments from IPOS Singapore and USTR.

Read more about AI cannot be an inventor rules USPTO, IPO extends SIPP Scheme and other patent news

Partial activity resumes at IPO amidst extended national lockdown

The Indian Patent Office has resumed partial operations amid the extended national lockdown, resulting in a marked increase in patent publications, grants, and design registrations. This update provides an objective overview of key statistics and city-wise contributions to intellectual property filings.

Read more about Partial activity resumes at IPO amidst extended national lockdown